Programmed cell death 1 (PD‐1) and its ligand PD‐L1 are required for allograft tolerance
Open Access
- 26 September 2007
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 37 (10) , 2983-2990
- https://doi.org/10.1002/eji.200737583
Abstract
Programmed cell death-1 (PD-1, CD279) and its widely expressed, inducible ligand, PD-L1 (CD274), together dampen T cell activation, but whether they are essential for allograft tolerance is unknown. We show, using gene-deficient mice and blocking mAbs in wild-type mice, that costimulation blockade is ineffectual in PD-1–/– or PD-L1–/– allograft recipients, or in wild-type allograft recipients treated with anti-PD-1 or anti-PD-L1 mAb. Alloreactive PD-1–/– CD4 and CD8 T cells had enhanced proliferation and cytokine production compared to wild-type controls, and anergy could not be induced in PD-1-deficient CD4 T cells. We conclude that without inhibitory signals from PD-1 ligation, alloantigen-induced T cell proliferation and expansion cannot be regulated by costimulation blockade, and peripheral tolerance induction cannot occur.Keywords
This publication has 34 references indexed in Scilit:
- Upregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+T Cells Associated with Reversible Immune DysfunctionJournal of Virology, 2007
- Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3Cardiovascular Research, 2007
- Involvement of the Programmed Death-1/Programmed Death-1 Ligand Pathway in CD4+CD25+ Regulatory T-Cell Activity to Suppress Alloimmune ResponsesTransplantation, 2007
- Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1)International Immunology, 2007
- Genetics of autoimmune diseases — disorders of immune homeostasisNature Reviews Genetics, 2006
- Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonistJournal of Clinical Investigation, 2006
- Tissue expression of PD-L1 mediates peripheral T cell toleranceThe Journal of Experimental Medicine, 2006
- The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) MiceThe Journal of Experimental Medicine, 2003
- Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient MiceScience, 2001
- Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytesInternational Immunology, 1996